European CHMP recommend license extension of posaconazole (Noxafil) for fungal infections

The licence extension recommended for approval is for use in invasive aspergillosis in adults and children above 2 years age and 40kg weight with disease that is refractory to amphotericin B or itraconazole or in patients who are intolerant of these medicines.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news